Hilar Cholangiocarcinoma with Para-Aortic Lymph Node Metastasis Treated with Chemoimmunotherapy and Conversion Surgery: A Case Report
Chemoimmunotherapy with durvalumab as a first-line treatment for unresectable CC has shown promising results. Immunotherapy with durvalumab, followed by conversion surgery, may improve the prognosis of patients with unresectable CC.
Authors
- Yuichiro Kajiwara
- Norifumi Iseda (ORCID: https://orcid.org/0000-0001-8589-0038)
- T. Watanabe (ORCID: https://orcid.org/0000-0003-0595-5490)
- Kazuhito Minami (ORCID: https://orcid.org/0000-0002-7155-054X)
- Nobuaki Azemoto
- Hironori Ochi (ORCID: https://orcid.org/0000-0002-4112-1015)
- Tomoyuki Yokota (ORCID: https://orcid.org/0000-0003-1546-8864)
- Kôichi Kimura (ORCID: https://orcid.org/0000-0003-4116-4135)
- Michiko Amano
- Yumiko Yasui
- Takaaki Tanaka (ORCID: https://orcid.org/0000-0001-8264-9468)
- Yoshinari Nobuto
- H Yano (ORCID: https://orcid.org/0000-0002-3206-0361)
- Takashi Nishizaki
- Ryosuke Minagawa
- Fang Cao (ORCID: https://orcid.org/0000-0001-8402-4250)
Institutions
- Matsuyama Red Cross Hospital (JP)
Publication Details
- Journal
- Surgical Case Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0023
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01